Chevron Committees: Board Nominating and Governance; Management Compensation
Current Public Company Directorships: Amgen Inc.; Apple Inc.; Uber Technologies, Inc.
Dr. Sugar is a senior advisor to various businesses and organizations, including Ares Management LLC, a private investment firm; Bain & Company, a global consulting firm; Temasek Americas Advisory Panel, a private investment company based in Singapore; and the G100 and World 50 peer-to-peer exchanges for current and former senior executives and directors from some of the world’s largest companies. He is also an advisor to Northrop Grumman Corporation (“Northrop Grumman”), a global aerospace and defense company, and was previously Northrop Grumman’s Chairman and Chief Executive Officer, from 2003 until his retirement in 2010, and President and Chief Operating Officer, from 2001 until 2003. He joined Northrop Grumman in 2001, having previously served as President and Chief Operating Officer of Litton Industries, Inc., a developer of military products, and earlier as an executive of TRW Inc., a developer of missile systems and spacecraft.
Prior Public Company Directorships (within last five years): Air Lease Corporation
Other Directorships and Memberships: Los Angeles Philharmonic Association; National Academy of Engineering; Nexli Building Solutions, Inc.; UCLA Anderson School of Management Board of Visitors; University of Southern California
Skills and Qualifications
Business Leadership / Operations: Served seven years as CEO of Northrop Grumman. Held senior management and executive positions, including service as COO, at Northrop Grumman, Litton Industries, Inc., and TRW Inc.
Environmental Affairs: As Chairman, CEO, and President of Northrop Grumman, oversaw environmental assessments and remediations at shipyards and aircraft and electronics factories.
Finance: Former CFO of Fortune 500 company. More than three decades of financial responsibility and experience at Northrop Grumman, Litton Industries, Inc., and TRW Inc. Current Audit Committee Chair at Apple Inc. and former Audit Committee Chair at Chevron.
Global Business / International Affairs: Former CEO of Fortune 500 company with extensive international operations. Current and former director of companies with international operations.
Government / Regulatory / Public Policy: At Northrop Grumman, a key government contractor, oversaw development of weapons and other technologies. Appointed by the President of the United States to the National Security Telecommunications Advisory Committee. Former director of the World Affairs Council of Los Angeles.
Science / Technology / Engineering: B.S., M.S., and Ph.D. in engineering from the University of California at Los Angeles. Served in a variety of senior management and executive positions at Northrop Grumman, Litton Industries, Inc., and TRW Inc., requiring expertise in engineering and technology. Director at Amgen Inc., a biotechnology company; Apple Inc., a designer, manufacturer, and marketer of, among other things, personal computers and mobile communication and media devices; Uber Technologies, Inc., a technology company; and former director at BeyondTrust, a global cybersecurity company. Member of National Academy of Engineering.
What is Ronald D. Sugar's net worth?
The estimated net worth of Ronald D. Sugar is at least $4.46 million as of May 12th, 2021. Mr. Sugar owns 16,927 shares of Amgen stock worth more than $4,458,233 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Sugar may own. Learn More about Ronald D. Sugar's net worth.
How do I contact Ronald D. Sugar?
Has Ronald D. Sugar been buying or selling shares of Amgen?
Ronald D. Sugar has not been actively trading shares of Amgen during the past quarter. Most recently, Ronald D. Sugar sold 1,000 shares of the business's stock in a transaction on Wednesday, May 12th. The shares were sold at an average price of $250.59, for a transaction totalling $250,590.00. Following the completion of the sale, the director now directly owns 16,927 shares of the company's stock, valued at $4,241,736.93. Learn More on Ronald D. Sugar's trading history.
Who are Amgen's active insiders?
Are insiders buying or selling shares of Amgen?
During the last year, insiders at the medical research company sold shares 1 times. They sold a total of 2,117 shares worth more than $662,811.53. The most recent insider tranaction occured on May, 3rd when SVP Nancy A Grygiel sold 2,117 shares worth more than $662,811.53. Insiders at Amgen own 0.7% of the company.
Learn More about insider trades at Amgen. Information on this page was last updated on 5/3/2024.
